Effect of Opiates on Growth Hormone Secretion in Acromegaly

Abstract

Morphine at doses of 5 mg and 10 mg does not stimulate growth hormone (GH) secretion in normal subjects, and its effect on GH secretion in acromegaly is not widely documented. We investigated the effect of 15 mg intravenous morphine on growth hormone in patients with active acromegaly compared to normal subjects (7 acromegalics and 5 controls). Their mean (± SEM) age was 30.5 ± 7.6 years and 29.5 ± 0.5 years, respectively. Basal and peak response of growth hormone after morphine was measured with simultaneous assay of cortisol to exclude the effect of stress. Mean (± SEM) basal growth hormone was 103.16 ± 28.04 ng/ml in acromegalics compared to 4.51 ± 1.43 ng/ml in controls. Morphine caused an elevation of growth hormone in both acromegalics and normal subjects (p < 0.05). However, the Δ (peak minus basal) response of growth hormone was comparable between the two groups. A concurrent fall in cortisol was noted after morphine in both the groups, excluding the effect of stress on growth hormone. We conclude that higher doses (15 mg) of morphine are required to stimulate GH secretion in normal subjects, and that opioids exert a positive modulating effect on growth hormone secretion in patients with active acromegaly suggesting partial autonomy of the pituitary tumor.

Key words

Cortisol - Opioid peptides - Somatotropinoma

References

• 1 Pfeiffer A, Herz A. Endocrine actions of opioids.  Horm Metabol Res. 1984;  16 386-397
• 2 Giustina A, Veldhuis J D. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.  Endocr Rev. 1998;  19 717-797
• 3 Serri O, Rasio E, Somma M. Effects of naloxone on insulin-induced release of pituitary hormones.  J Clin Endocrinol Metab. 1981;  53 206-208
• 4 Moretti C, Fabbri A, Gnessi L, Cappa M, Calzolari A, Fraioli F, Grossman A, Besser G M. Naloxone inhibits exercise induced release of prolactin and growth hormone in atheletes.  Clin Endocrinol (Oxf). 1983;  98 135-138
• 5 Hemmings R, Fox G, Tolis G. Effect of morphine on the hypothalamic-pituitary axis in postmenopausal women.  Fertil Steril. 1982;  37 389-391
• 6 Tolis G, Hickey J, Guyda H. Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man.  J Clin Endocrinol Metab. 1975;  41 797-800
• 7 Tolis G, Jukier L, Wiesen M, Krieger D T. Effect of naloxone on pituitary hypersecretory syndromes.  J Clin Endocrinol Metab. 1982;  54 780-784
• 8 Tamotsu A, Masuda A, Hotta M, Yamauchi N, Hizerka N, Takano K, Demura H, Shizume K. Effects of ingestion of glucose on GH and TSH secretion: evidence for stimulation of somatostatin release from the hypothalamus by acute hyperglycemia in normal man and its impairment in acromegalic patients.  Life Sci. 1989;  44 431-438
• 9 Balsa J A, Varela C, Lucas T, Uria-Garcia J, Burcelo B, Sancho-Rof J M. Varying additive effects of bromocryptive with two somatostatin analogs in cultures of GH secreting adenomas.  Horm Metab Res. 2002;  34 435-440
• 10 Drouva S V, Epelbaum J, Tapia-Arancibia L, Laplante E, Kordon C. Opiate receptors modulate GHRH and SRIF release from mediobasal hypothalamic neurons.  Neuroendocrinology. 1981;  32 163-167
• 11 Lien E L, Fenichet R L, Garsky V, Sarantakis D, Grant N H. Enkephalin-stimulated prolactin release.  Life Sci. 1976;  19 837-840
• 12 Panerai A E, Casanueva F, Martini A, Mantegazza P, Maria Di Guilio A. Opiates act centrally on GH and PRL release.  Endocrinology. 1981;  108 2400-2402
• 13 Wehrenberg W B, Bloch B, Ling N. Pituitary secretion of growth hormone in response to opioid peptides and opiates is mediated through growth hormone-releasing factor.  Neuroendocrinology. 1985;  41 13-16
• 14 Delitala G, Grossman A, Besser G M. Opiate peptides control GH through a cholinergic mechanism in men.  Clin Endocrinol (Oxf). 1983;  18 401-405
• 15 Buckingham J C. Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides.  Neuroendocrinology. 1982;  35 111-116
• 16 Grossman A, Besser G M. Opiates control ACTH through noradrenergic mechanism.  Clin Endocrinol (Oxf). 1982;  17 287-290